Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

572 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'.
Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G. Iudici M, et al. Among authors: valentini g. Autoimmun Rev. 2016 Feb;15(2):202. doi: 10.1016/j.autrev.2015.06.007. Epub 2015 Jun 26. Autoimmun Rev. 2016. PMID: 26123179 No abstract available.
Therapy of systemic sclerosis.
Valentini G. Valentini G. Reumatismo. 2004 Jan-Mar;56(1):1-8. doi: 10.4081/reumatismo.2004.1. Reumatismo. 2004. PMID: 15154394 Review.
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin.
Perosa F, Prete M, Di Lernia G, Ostuni C, Favoino E, Valentini G. Perosa F, et al. Among authors: valentini g. Autoimmun Rev. 2016 Jan;15(1):102-9. doi: 10.1016/j.autrev.2015.10.001. Epub 2015 Oct 9. Autoimmun Rev. 2016. PMID: 26455561 Review.
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve.
Riccardi A, Marcoccia A, Borgia A, Guastafierro T, Bondanini F, Fasano S, Irace R, Messiniti V, Sanduzzi A, Bocchino M, Ciani A, D'Alto M, Argiento P, De Matteis GM, Spanò A, Valentini G. Riccardi A, et al. Among authors: valentini g. Autoimmun Rev. 2019 Sep;18(9):102358. doi: 10.1016/j.autrev.2019.102358. Epub 2019 Jul 16. Autoimmun Rev. 2019. PMID: 31323358 No abstract available.
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A; Imatinib in Scleroderma Italian Study Group. Fraticelli P, et al. Among authors: valentini g. Arthritis Res Ther. 2014 Jul 8;16(4):R144. doi: 10.1186/ar4606. Arthritis Res Ther. 2014. PMID: 25007944 Free PMC article. Clinical Trial.
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S, Valentini G. Iudici M, et al. Among authors: valentini g. Semin Arthritis Rheum. 2015 Feb;44(4):437-44. doi: 10.1016/j.semarthrit.2014.09.003. Epub 2014 Sep 8. Semin Arthritis Rheum. 2015. PMID: 25282395
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
Adler S, Huscher D, Siegert E, Allanore Y, Czirják L, DelGaldo F, Denton CP, Distler O, Frerix M, Matucci-Cerinic M, Mueller-Ladner U, Tarner IH, Valentini G, Walker UA, Villiger PM, Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network. Adler S, et al. Among authors: valentini g. Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z. Arthritis Res Ther. 2018. PMID: 29382380 Free PMC article.
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG. Giacomelli R, et al. Among authors: valentini g. Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Autoimmun Rev. 2017. PMID: 28705780 Review.
Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
Valentini G. Valentini G. Autoimmun Rev. 2015 Mar;14(3):210-3. doi: 10.1016/j.autrev.2014.11.002. Epub 2014 Nov 18. Autoimmun Rev. 2015. PMID: 25461837 Review.
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?
Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G. Iudici M, et al. Among authors: valentini g. Autoimmun Rev. 2015 Jul;14(7):575-8. doi: 10.1016/j.autrev.2015.02.002. Epub 2015 Feb 21. Autoimmun Rev. 2015. PMID: 25709096 Review.
572 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback